Understanding the benefits of matrix converters for EV chargers and a comparison of different matrix converter topologies.
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results